David Kaufman
Vermögen: 521 $ am 31.05.2026
Vermögen: 521 $ am 31.05.2026
Dr. David R.
Kaufman is a Partner at Third Rock Ventures LLC, an Independent Director at HOOKIPA Pharma, Inc. and a Partner at Third Rock Ventures LP.
He is on the Board of Directors at Abata Therapeutics, Inc., HOOKIPA Pharma, Inc., International Society for Biological Therapy of Cancer and Society For Immunotherapy of Cancer.
Dr. Kaufman was previously employed as a Chief Medical Officer by Bill & Melinda Gates Medical Research Institute and a Head-Translational Oncology by Merck Research Laboratories Massachusetts LLC.
He received his undergraduate degree from Swarthmore College, a doctorate degree from The Rockefeller University and a doctorate degree from Weill Cornell Medical College.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 04.06.2025 | 457 ( 0 % ) | 521 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| HOOA PHARPAR | Direktor/Vorstandsmitglied | 25.04.2019 |
International Society for Biological Therapy of Cancer
International Society for Biological Therapy of Cancer Miscellaneous Commercial ServicesCommercial Services Operates as professional society of influential scientists, academicians, researchers, clinicians and government representatives | Direktor/Vorstandsmitglied | - |
Third Rock Ventures LP
Third Rock Ventures LP Investment ManagersFinance Acts as Venture Capital Fund | Corporate Officer/Principal | - |
Society For Immunotherapy of Cancer
Society For Immunotherapy of Cancer Miscellaneous Commercial ServicesCommercial Services Operates as a member-driven organization specifically dedicated to improving cancer patient outcomes | Direktor/Vorstandsmitglied | - |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Private Equity Investor | 01.09.2020 |
Abata Therapeutics, Inc.
Abata Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treg cell therapies for serious autoimmune and inflammatory diseases | Direktor/Vorstandsmitglied | 09.03.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Corporate Officer/Principal | 01.01.2018 |
Bill & Melinda Gates Medical Research Institute
Bill & Melinda Gates Medical Research Institute Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organization dedicated to the development of novel biomedical interventions | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 11 |
|---|---|
Third Rock Ventures LP
Third Rock Ventures LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Swarthmore College
Swarthmore College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Rockefeller University
The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
International Society for Biological Therapy of Cancer
International Society for Biological Therapy of Cancer Miscellaneous Commercial ServicesCommercial Services Operates as professional society of influential scientists, academicians, researchers, clinicians and government representatives | Commercial Services |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Finance |
Weill Cornell Medical College
Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HOOKIPA Pharma, Inc.
HOOKIPA Pharma, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company which develops pharmaceutical products for immunotherapeutics targeting infectious diseases and cancers | Health Technology |
Bill & Melinda Gates Medical Research Institute
Bill & Melinda Gates Medical Research Institute Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organization dedicated to the development of novel biomedical interventions | Commercial Services |
Society For Immunotherapy of Cancer
Society For Immunotherapy of Cancer Miscellaneous Commercial ServicesCommercial Services Operates as a member-driven organization specifically dedicated to improving cancer patient outcomes | Commercial Services |
Abata Therapeutics, Inc.
Abata Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treg cell therapies for serious autoimmune and inflammatory diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen